Lazard Asset Management
PNT

Lazard Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Lazard Asset Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,704
Closed -$77K – 2534
2023
Q3 		$77K Sell
11,704
-3,923
-25% -$32.6K ﹤0.01% 1727
2023
Q2 		$140K Buy
15,627
+6,787
+77% +$59.9K ﹤0.01% 1456
2023
Q1 		$64K Buy
+8,840
New +$65.6K ﹤0.01% 1715

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Lazard Asset Management's PNT Position: Q4 2023 in Review

Lazard Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 11,704 shares — an estimated $77K sold.

Lazard Asset Management first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $140K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Lazard Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Lazard Asset Management sold 11,704 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $77K.
  • Lazard Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Lazard Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $140K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.